SS

Sandip Sharma

Active Director Director DIN 11627247
DIN 11627247 First appointment Mar 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sandip Sharma

Data last updated:

Sandip Sharma is a Director at Asston Pharmaceuticals Limited (since 2026). The company operates in Pharma.

DIN 11627247
Primary Designation Director
Industry Pharma
First Appointment 30 Mar 2026
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Asston Pharmaceuticals Limited U24304MH2019PLC324187
Director30 Mar 20262019Active

Directorship timeline

Open interactive timeline →
Asston Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Sandip Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandip Sharma

Sandip Sharma currently holds 1 directorship: Asston Pharmaceuticals Limited (Director, since 30 Mar 2026).

Sandip Sharma was first appointed on 30 Mar 2026 as Director at Asston Pharmaceuticals Limited.

The current boards of Sandip Sharma's companies include Ashish Narayan Sakalkar (Asston Pharmaceuticals Limited), Rishabh Kumar Jain (Asston Pharmaceuticals Limited), Rishi Upadhaya (Asston Pharmaceuticals Limited), Sachin Chandrakant Badakh (Asston Pharmaceuticals Limited), Saili Jayaram More (Asston Pharmaceuticals Limited), Saili Jayaram More (Asston Pharmaceuticals Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available